No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
CLPT250117C17500
- 0.65
- +0.16+32.65%
15min DelayClose Dec 26 16:00 ET
0.75High0.65Low
0.70Open0.49Pre Close8 Volume1.01K Open Interest17.50Strike Price575.00Turnover74.87%IV10.13%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier21DDays to Expiry0.65Extrinsic Value100Contract SizeAmericanOptions Type0.4106Delta0.1300Gamma20.60Leverage Ratio-0.0281Theta0.0035Rho8.46Eff Leverage0.0155Vega
Intraday
- 5D
- Daily
News
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Announces Target Price $17
Sector Update: Health Care Stocks Advance Pre-Bell Thursday
Sector Update: Health Care
Top Premarket Gainers
ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain
The ClearPoint Neuro, Inc. (NASDAQ:CLPT) Third-Quarter Results Are Out And Analysts Have Published New Forecasts